Publications
Columns
News
App Notes
Conferences
Webcasts
Resources
Directory
Subscribe

Spotlight -

Watertight Analytical Solutions to Meet EU Directive 2020/2184 |

Clarus® Nova GC|

Measure Your Furanocoumarins Like a Pro

Deanna Hunt, KBI Biopharma

Articles by Deanna Hunt, KBI Biopharma

The Evolving Bioconjugate Landscape

ByLance Cadang, Genentech,Deanna Hunt, KBI Biopharma,Colette Quinn, Waters Corporation,Zhengqi Zhang, Merck & Co

June 29th 2026

Sponsored

Reactions to how the bioconjugate field has transformed since 2016 and where it is headed next.

Colette Quinn, Senior Director and Portfolio Owner at Waters Corporation, frames the growing complexity of the bioconjugate landscape, from ADCs to antibody-oligonucleotide conjugates (AOCs) and bioconjugate vaccines. She introduces the panel of subject matter experts joining the discussion: Deanna Hunt, Senior Director of Business Development at KBI Biopharma, Lance Cadang, a scientist in Genentech’s Synthetic Molecule Analytical Chemistry division and Zhengqi Zhang, Associate Principal Scientist at Merck & Co.

Next-Generation Bioconjugation: Meet the Experts

ByLance Cadang, Genentech,Deanna Hunt, KBI Biopharma,Colette Quinn, Waters Corporation,Zhengqi Zhang, Merck & Co

June 29th 2026

Sponsored

Meet the panel of experts driving the conversation on today's most pressing challenges and opportunities in bioconjugate characterization.

Latest Updated Articles

Trending on LCGC International

HPLC Confirms Creatine Uptake in Rainbow Trout

Chromatographic and LC–MS Strategies for Therapeutic Oligonucleotide Characterization

The Gains in Peak and Intensity Identification

The Future of Chromatography in an Autonomous Laboratory

Managing bias in LC-UV potency assays